Zura Bio Limited
ZURA
$3.51
-$0.21-5.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.77% | -94.61% | -6.12% | 13.18% | 32.61% |
| Total Depreciation and Amortization | 875.00% | 2,700.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -38.60% | 115.77% | -38.83% | -45.23% | -61.75% |
| Change in Net Operating Assets | -117.77% | -76.93% | 12.67% | -54.91% | -3.66% |
| Cash from Operations | -150.46% | -139.09% | -103.57% | -86.50% | -98.75% |
| Capital Expenditure | -370.00% | -617.65% | -1,571.43% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 100.00% | 100.00% | 37.50% | 68.93% |
| Cash from Investing | 97.20% | 98.32% | 99.10% | 36.56% | 68.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -92.07% | -82.51% | 14.69% | -43.66% | -43.66% |
| Repurchase of Common Stock | -- | -1,500.00% | -1,345.45% | -1,345.45% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -101.72% | -102.13% | 258.52% | 294.95% | 437.23% |
| Cash from Financing | -96.12% | -90.37% | 52.07% | -9.44% | -13.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -158.32% | -144.89% | 76.11% | -21.93% | -16.43% |